Changes of Urinary Cytokines in Non-Diabetic Obese Patients After Laparoscopic Sleeve Gastrectomy

References

• Goktas Z, Moustaid-Moussa N, Shen C, Boylan M, Mo H, Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;10(4):69.
   Google Scholar
• Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20(23):6008. doi:10.3390/ijms20236008
   PubMed Web of Science ®Google Scholar
• Lewko WM, Oldham RK. Cytokines. In: Oldham RK, Dillman RO, editors. Principles of Cancer Biotherapy. Dordrecht: Springer; 2009.
   Google Scholar
• Hunley TE, Ma L, Kon V. Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens. 2010;19(3):227–234. doi:10.1097/MNH.0b013e3283374c09
   PubMedGoogle Scholar
• Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokines. 2009;47(1):37–42. doi:10.1016/j.cyto.2009.04.001
   Google Scholar
• Qureshi A, Frankel AH, Tam FWK. CCL18/PARC, a novel cytokine present in urine of diabetic patients, may be involved in regulation of inflammation and fibrosis in diabetic nephropathy. Am Soc Nephrol Renal Week. 2007.
   Google Scholar
• Bruchfeld A, Carrero JJ, Qureshi AR, et al. Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. Mol Med. 2009;15(3–4):70–75. doi:10.2119/molmed.2008.00109
   PubMed Web of Science ®Google Scholar
• Hell E, Miller K. Criteria for selection of patients for bariatric surgery. Zentralbl Chir. 2002;127(12):1035–1037. doi:10.1055/s-2002-36375
   PubMed Web of Science ®Google Scholar
• Yermilov I, McGory ML, Shekelle PW, Ko CY, Maggard MA. Appropriateness criteria for bariatric surgery: beyond the NIH guidelines. Obesity (Silver Spring). 2009;17(8):1521–1527. doi:10.1038/oby.2009.78
   PubMed Web of Science ®Google Scholar
• Sjöström L, Lindroos AK, Peltonen M, et al.; Obese subjects study scientific group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–2693. Swedish. doi:10.1056/NEJMoa035622
   PubMed Web of Science ®Google Scholar
• Kulick D, Hark L, Deen D. The bariatric surgery patient: a growing role for registered dietitians. J Am Diet Assoc. 2010;110(4):593–599. doi:10.1016/j.jada.2009.12.021
   PubMedGoogle Scholar
• Hoyuela C. Five-year outcomes of laparoscopic sleeve gastrectomy as a primary procedure for morbid obesity: a prospective study. World J Gastrointest Surg. 2017;9(4):109–117. doi:10.4240/wjgs.v9.i4.109
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Byrne CD. Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrol Dial Transplant. 2010;25(10):3142–3147. doi:10.1093/ndt/gfq347
   PubMed Web of Science ®Google Scholar
• Bueter M, Dubb SS, Gill A, et al. Renal cytokines improve early after bariatric surgery. Br J Surg. 2010;97(12):1838–1844. doi:10.1002/bjs.7264
   PubMed Web of Science ®Google Scholar
• Lee H, Lee S, Choue R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr. 2013;16(3):143–152. doi:10.5223/pghn.2013.16.3.143
   PubMedGoogle Scholar
• Baracho NCDV, Silveira KD, Rocha NP, et al. Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats. J Bras Nefrol. 2017;39(2):108–118. doi:10.5935/0101-2800.20170028
   PubMedGoogle Scholar
• Li J, Tang Y, Tang PMK, et al. Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice. Mol Ther. 2018;26(10):2523–2532. doi:10.1016/j.ymthe.2018.07.014
   PubMed Web of Science ®Google Scholar
• Andres-Hernando A, Dursun B, Altmann C, et al. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy. Nephrol Dial Transplant. 2012;27(12):4339–4347. doi:10.1093/ndt/gfs256
   PubMed Web of Science ®Google Scholar
• Eisenhardt SU, Thiele JR, Bannasch H, Stark GB, Peter K. C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle. 2009;8(23):3885–3892. doi:10.4161/cc.8.23.10068
   PubMed Web of Science ®Google Scholar
• Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010;2010:535918. doi:10.1155/2010/535918
   PubMed Web of Science ®Google Scholar
• Kones R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease–a perspective. Drug Des Devel Ther. 2010;4:383–413. doi:10.2147/DDDT.S10812
   PubMed Web of Science ®Google Scholar
• McDonald S, Maguire G, Duarte N, Wang XL, Hoy W. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian aboriginal community. Clin Sci (Lond). 2004;106(2):121–128. doi:10.1042/CS20030186
   PubMed Web of Science ®Google Scholar
• Schraufstatter IU, Zhao M, Khaldoyanidi SK, DiScipio RG. The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum. Immunology. 2012;135(4):287–298. doi:10.1111/j.1365-2567.2011.03541.x
   PubMed Web of Science ®Google Scholar
• Eriksson HD, Petrus P, Gao H, et al. Adipose and circulating CCL18 levels associated with metabolic risk factors in women. J Clin Endocrinol Metab. 2016;101(11):4021–4029. doi:10.1210/jc.2016-2390
   PubMed Web of Science ®Google Scholar
• Forssmann U, Magert HJ, Adermann K, Escher SE, Forssmann WG. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15. J Leukoc Biol. 2001;70:357–366.
   PubMed Web of Science ®Google Scholar
• Kitagawa K, Wada T, Furuichi K, et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol. 2004;165(1):237–246. doi:10.1016/S0002-9440(10)63292-0
   PubMed Web of Science ®Google Scholar
• Li JH, Tang Y, Lv J, et al. Macrophage migration inhibitory factor promotes renal injury induced by ischemic-reperfusion. J Cell Mol Med. 2019;23(6):3867–3877. doi:10.1111/jcmm.14234
   PubMed Web of Science ®Google Scholar
• Rojano-Rodríguez ME, Valenzuela-Salazar C, Cárdenas-Lailson LE, Romero Loera LS, Torres-Olalde M, Moreno-Portillo M. C-reactive protein level in morbidly obese patients before and after bariatric surgery. Rev Gastroenterol Mex. 2014;79(2):90–95. doi:10.1016/j.rgmx.2013.11.002
   PubMedGoogle Scholar
• Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters, and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr. 2006;25(3):400–408. doi:10.1016/j.clnu.2005.11.014
   PubMed Web of Science ®Google Scholar
• de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26(Suppl 4):S21–4. doi:10.1038/sj.ijo.0802213
   PubMed Web of Science ®Google Scholar
• Ritz E. Bariatric surgery and the kidney—much benefit, but also potential harm. Clin Kidney J. 2013;6(4):368–372. doi:10.1093/ckj/sfs161
   PubMedGoogle Scholar
• Holcomb CN, Goss LE, Almehmi A, Grams JM, Corey BL. Bariatric surgery is associated with renal function improvement. Surg Endosc. 2018;32(1):276–281. doi:10.1007/s00464-017-5674-y
   PubMed Web of Science ®Google Scholar
• Kun L, Zou J, Zhibin Y, Jianzhong D, Han X. Laparoscopic sleeve gastrectomy improves glomerular filtration rate in morbidly obese patients with impaired kidney function. J Am Coll Surg. 2017;225(4):e3.
   Web of Science ®Google Scholar
• Li K, Zou J, Ye Z, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta-analysis. PLoS One. 2016;11(10):e0163907. doi:10.1371/journal.pone.0163907
   PubMed Web of Science ®Google Scholar
• Friedman AN, Strother M, Quinney SK, et al. Measuring the glomerular filtration rate in obese individuals without overt kidney disease. Nephron Clin Pract. 2010;116:c224–34. doi:10.1159/000317203
   PubMedGoogle Scholar
• Prigent A. Monitoring renal function and limitations of renal function tests. Semin Nucl Med. 2008;38(1):32–46. doi:10.1053/j.semnuclmed.2007.09.003
   PubMed Web of Science ®Google Scholar